Trial
NCT02658084
Vinorelbine With Trastuzumab Emtansine in Pre-Treated HER2-Positive Metastatic Breast Cancer
Phase ITERMINATEDSAFETYConfidence: HIGH
Sponsor
University of Miami
Collaborators
Genentech, Inc.
Condition
Breast Cancer
Intervention
Vinorelbine
Why stopped
Terminated due to low accrual and toxicity concerns.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-04-17